Reduction in cardiovascular disease events in patients with type 2 diabetes mellitus treated with a sodium–glucose cotransporter 2 inhibitor versus a dipeptidyl peptidase‐4 inhibitor: A real‐world retrospective administrative database analysis in Japan

AIMS/INTRODUCTION: To evaluate the benefit of sodium–glucose cotransporter 2 inhibitors (SGLT2i) versus dipeptidyl peptidase‐4 inhibitors (DPP4i) in reducing cardiovascular disease (CVD) events in patients with type 2 diabetes mellitus with and without a CVD history. MATERIALS AND METHODS: This retr...

Descripción completa

Detalles Bibliográficos
Autores principales: Kashiwagi, Atsunori, Shoji, Shingo, Onozawa, Satoshi, Kosakai, Yoshinori, Waratani, Miina, Ito, Yuichiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9248422/
https://www.ncbi.nlm.nih.gov/pubmed/35243799
http://dx.doi.org/10.1111/jdi.13785

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9248422/
https://www.ncbi.nlm.nih.gov/pubmed/35243799
http://dx.doi.org/10.1111/jdi.13785

Ejemplares similares